Cargando…

Evaluating the Efficacy and Safety of 4% 5-Fluorouracil Cream in Patients with Actinic Keratosis: An Expert Opinion

Actinic keratosis is a lesion that develops in sun-exposed areas of the skin and is considered to be a precancerous condition or an early in situ squamous cell carcinoma. Treatment of actinic keratosis is important for reducing skin cancer risk, with treatment choice based on patient-, lesion- and t...

Descripción completa

Detalles Bibliográficos
Autores principales:	STOCKFLETH, Eggert, HEPPT, Markus V., BÉGEAULT, Nathalie, DELARUE, Alain
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medical Journals Sweden, on behalf of the Society for Publication of Acta Dermato-Venereologica 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10680462/ https://www.ncbi.nlm.nih.gov/pubmed/37982726 http://dx.doi.org/10.2340/actadv.v103.11954

Ejemplares similares

Intensity of Local Skin Reactions During 5-Fluorouracil Treatment Related to the Number of Actinic Keratosis Lesions: A Post Hoc, Exploratory Analysis
por: Stockfleth, Eggert, et al.
Publicado: (2021)

The Overall Number of Actinic Keratosis Lesions Is Not Predictable by the Number of Visible Lesions: Consequences for Field-Directed Therapies
por: Stockfleth, Eggert, et al.
Publicado: (2021)

Severity of Local Skin Reactions with 4% 5-Fluorouracil Plus Emollient versus 4% 5-Fluorouracil Alone in Patients with Actinic Keratosis: A Single-Blind Randomised Trial
por: Stockfleth, Eggert, et al.
Publicado: (2023)

Efficacy Endpoints in Clinical Trials in Actinic Keratosis
por: Skov, Torsten, et al.
Publicado: (2018)

Efficacy and Safety of 5-Fluorouracil 0.5%/Salicylic Acid 10% in the Field-Directed Treatment of Actinic Keratosis: A Phase III, Randomized, Double-Blind, Vehicle-Controlled Trial
por: Stockfleth, Eggert, et al.
Publicado: (2016)

Erratum to: Efficacy and Safety of 5-Fluorouracil 0.5%/Salicylic Acid 10% in the Field-Directed Treatment of Actinic Keratosis: A Phase III, Randomized, Double-Blind, Vehicle-Controlled Trial
por: Stockfleth, Eggert, et al.
Publicado: (2017)

Tirbanibulin for Actinic Keratosis: Insights into the Mechanism of Action
por: Schlesinger, Todd, et al.
Publicado: (2022)

Real-World Experience With Topical 5-Fluorouracil 4% (40 mg/g) Cream for the Treatment of Actinic Keratosis
por: Briatico, Giulia, et al.
Publicado: (2023)

Eyebrow hairs from actinic keratosis patients harbor the highest number of cutaneous human papillomaviruses
por: Schneider, Ines, et al.
Publicado: (2013)

Topical Calcipotriol Plus 5-Fluorouracil Immunotherapy for Actinic Keratosis Treatment
por: Azin, Marjan, et al.
Publicado: (2022)

Tirbanibulin 1% Ointment Significantly Reduces the Actinic Keratosis Area and Severity Index in Patients with Actinic Keratosis: Results from a Real-World Study
por: Kirchberger, Michael Constantin, et al.
Publicado: (2023)

Patient‐reported skin reactions to 5% 5‐fluorouracil in treatment of actinic keratosis
por: Ahmady, S., et al.
Publicado: (2021)

Immune-mediated changes in actinic keratosis following topical treatment with imiquimod 5% cream
por: Torres, Abel, et al.
Publicado: (2007)

A Critical Appraisal of Evidence- and Consensus-Based Guidelines for Actinic Keratosis
por: Wessely, Anja, et al.
Publicado: (2021)

Expert Recommendations on Facilitating Personalized Approaches to Long-term Management of Actinic Keratosis: The Personalizing Actinic Keratosis Treatment (PAKT) Project
por: MORTON, Colin, et al.
Publicado: (2023)

A consensus approach to improving patient adherence and persistence with topical treatment for actinic keratosis
por: Stockfleth, Eggert, et al.
Publicado: (2015)

Long-term efficacy of interventions for actinic keratosis: protocol for a systematic review and network meta-analysis
por: Steeb, Theresa, et al.
Publicado: (2019)

Comparative study of actinic keratosis treatment with 3% diclofenac sodium and 5% 5-fluorouracil()
por: Segatto, Majoriê Mergen, et al.
Publicado: (2013)

How to Assess the Efficacy of Interventions for Actinic Keratosis? A Review with a Focus on Long-Term Results
por: Steeb, Theresa, et al.
Publicado: (2021)

Comparative Efficacy and Safety of Tirbanibulin for Actinic Keratosis of the Face and Scalp in Europe: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
por: Heppt, Markus V., et al.
Publicado: (2022)

Refusal of Retreatment With Topical 5-Fluorouracil Among Patients With Actinic Keratosis: Qualitative Analysis
por: Singh, Rohan, et al.
Publicado: (2023)

Daylight Photodynamic Therapy Versus 5-Fluorouracil for the Treatment of Actinic Keratosis: A Case Series
por: Galimberti, Gaston Nestor
Publicado: (2018)

A Systematic Review and Meta-Analysis of Interventions for Actinic Keratosis from Post-Marketing Surveillance Trials
por: Steeb, Theresa, et al.
Publicado: (2020)

Spontaneous regression rates of actinic keratosis: a systematic review and pooled analysis of randomized controlled trials
por: Steeb, Theresa, et al.
Publicado: (2022)

Harmonisation of Outcome Parameters and Evaluation (HOPE) for actinic keratosis: protocol for the development of a core outcome set
por: Heppt, Markus V., et al.
Publicado: (2019)

Actinic Keratosis: Rationale and Management
por: Dodds, Annabel, et al.
Publicado: (2014)

Optimal treatment of actinic keratosis
por: Goldenberg, Gary
Publicado: (2013)

Virtual consultation for actinic keratosis
por: Dhariwal, Sukhjit, et al.
Publicado: (2020)

The Genomic Landscape of Actinic Keratosis
por: Thomson, Jason, et al.
Publicado: (2021)

Evaluation of the therapeutic results of actinic keratosis treated with topical 5% fluorouracil by reflectance confocal laser microscopy: preliminary study
por: Ishioka, Priscila, et al.
Publicado: (2015)

Combination of 5-Fluorouracil with Photodynamic Therapy: Enhancement of Innate and Adaptive Immune Responses in a Murine Model of Actinic Keratosis()
por: Anand, Sanjay, et al.
Publicado: (2023)

Pigmented Actinic Keratosis: Case Report and Review of an Uncommon Actinic Keratosis Variant that can Mimic Melanoma
por: Abudu, Boya, et al.
Publicado: (2019)

Porokeratoma treated with topical 5% 5-fluorouracil cream
por: Li, Steve S., et al.
Publicado: (2021)

Use of Lesion Response Rate in Actinic Keratosis Trials
por: Szeimies, Rolf-Markus, et al.
Publicado: (2016)

Retinoids for prevention and treatment of actinic keratosis*
por: Ianhez, Mayra, et al.
Publicado: (2013)

Cyclooxygenase-2 expression in actinic keratosis
por: Adamska, Kinga, et al.
Publicado: (2018)

Earliest stage treatment of actinic keratosis with imiquimod 3.75% cream: Two case reports—Perspective for non melanoma skin cancer prevention
por: Kopera, Daisy
Publicado: (2020)

Cost for the treatment of actinic keratosis on the rise in Australia
por: Perera, Eshini, et al.
Publicado: (2014)

Non-adherence to topical treatments for actinic keratosis
por: Shergill, Bav, et al.
Publicado: (2013)

Cyclooxygenase in Cancer Prevention and Treatments for Actinic Keratosis
por: Thomas, Gareth J., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_8dfjeqm4hpm6siiqtqjop9canl